Orasure Technologies (OSUR) Cash from Investing Activities (2010 - 2025)
Orasure Technologies' (OSUR) quarterly Cash from Investing Activities came in at -$821000.0 in Q3 2025, down 111.2% year-on-year from $7.3 million in Q3 2024, and up 57.59% quarter-over-quarter from -$1.9 million in Q2 2025.
Orasure Technologies (OSUR) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Orasure Technologies has disclosed Cash from Investing Activities across 16 years of filings, most recently posting -$821000.0 for Q3 2025.
- Cash from Investing Activities for Q3 2025 came in at -$821000.0, down 111.2% year-over-year; the trailing twelve-month figure through Sep 2025 was -$7.9 million (down 164.52% YoY), and the FY2024 annual result was -$39.0 million, down 158.99% from the prior year.
- Cash from Investing Activities came in at -$821000.0 for Q3 2025 at Orasure Technologies, up from -$1.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $37.2 million in Q2 2023 to a low of -$46.5 million in Q1 2024.
- The 5-year median for Cash from Investing Activities is -$821000.0 (2025), against an average of $2.1 million.
- Across the five-year window, Cash from Investing Activities surged 507.41% in 2022 and sank 4679.53% in 2024, its largest moves.
- Orasure Technologies' Cash from Investing Activities stood at -$6.3 million in 2021, then soared by 507.41% to $25.6 million in 2022, then rose by 19.48% to $30.6 million in 2023, then sank by 117.98% to -$5.5 million in 2024, then soared by 85.05% to -$821000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$821000.0 (Q3 2025), -$1.9 million (Q2 2025), and $370000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Orasure Technologies | 304.09 Mn | 104.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -821,000.00 |
| Sep 30, 2025 | -821,000.00 |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 370,000.00 |
| Mar 31, 2025 | 370,000.00 |
| Dec 31, 2024 | -5.49 Mn |
| Dec 31, 2024 | -5.49 Mn |
| Sep 30, 2024 | 7.33 Mn |
| Sep 30, 2024 | 7.33 Mn |
| Jun 30, 2024 | 5.66 Mn |
| Jun 30, 2024 | 5.66 Mn |
| Mar 31, 2024 | -46.53 Mn |
| Mar 31, 2024 | -46.53 Mn |
| Dec 31, 2023 | 30.55 Mn |
| Dec 31, 2023 | 30.55 Mn |
| Sep 30, 2023 | -2.57 Mn |
| Sep 30, 2023 | -2.57 Mn |
| Jun 30, 2023 | 37.16 Mn |
| Jun 30, 2023 | 37.16 Mn |